1 October 2012 Evaluation and quantification of spectral information in tissue by confocal microscopy
Author Affiliations +
J. of Biomedical Optics, 17(10), 106011 (2012). doi:10.1117/1.JBO.17.10.106011
Abstract
A confocal imaging and image processing scheme is introduced to visualize and evaluate the spatial distribution of spectral information in tissue. The image data are recorded using a confocal laser-scanning microscope equipped with a detection unit that provides high spectral resolution. The processing scheme is based on spectral data, is less error-prone than intensity-based visualization and evaluation methods, and provides quantitative information on the composition of the sample. The method is tested and validated in the context of the development of dermal drug delivery systems, introducing a quantitative uptake indicator to compare the performances of different delivery systems is introduced. A drug penetration study was performed in vitro. The results show that the method is able to detect, visualize and measure spectral information in tissue. In the penetration study, uptake efficiencies of different experiment setups could be discriminated and quantitatively described. The developed uptake indicator is a step towards a quantitative assessment and, in a more general view apart from pharmaceutical research, provides valuable information on tissue composition. It can potentially be used for clinical in vitro and in vivo applications.
Maeder, Marquardt, Beer, Bergmann, Schmidts, Heverhagen, Zink, Runkel, and Fiebich: Evaluation and quantification of spectral information in tissue by confocal microscopy

1.

Introduction

The visualization of intrinsic and extrinsic substances in biological tissue is a very common task in the area of biomedical imaging. Fluorescence microscopy is a widely used technique to assess the local distribution of either intrinsic autofluorescent structures or incorporated fluorescent molecules. In the field of investigating drug delivery into biological tissue, especially skin tissue, fluorescent dyes are utilized in many cases as model agents. Amongst other techniques confocal,1 multiphoton23.4.5 and widefield6 microscopy is used to evaluate pharmaceutical transdermal and dermal delivery systems.78.9 Amongst others, highly potent approaches for delivery and therapy are micro-emulsion1011.12 and nanoparticle13 formulations. Transdermal delivery systems are used for systemic drug distribution. Therefore the amount that permeated through the skin is of interest. In vivo studies commonly analyze the drug concentration in blood while in vitro studies, for example, have to analyze the concentration in equivalent receptor fluids. The drug concentration is normally determined by enzyme-linked immunosorbent assay (ELISA) or high-performance liquid chromatography (HPLC). The focus of dermal delivery systems is the penetration of drugs into the skin layers. An important parameter that can be assessed microscopically using vertical slices of the tissue is the penetration depth. The origin of tissues can be from excised skin addressing in vitro studies or in case of in vivo studies from skin biopsies. However, elaborated approaches using tape-stripping and HPLC analysis are often used for evaluation. HPLC analysis allows quantification of the drug in the whole sample without showing the distribution. Microscopy on the other hand shows the pathways of the transport but lacks the possibility to quantify without further calibration efforts.1

Microscopic tissue imaging is very promising in terms of identifying pathways and providing further inside in penetration processes. However, a major problem is that tissue often shows strong autofluorescence. Especially skin is very complex and consists of various endogenous fluorophores, such as melanin, elastin, riboflavin and NAD(P)H2 and possesses a broad autofluorescence spectrum that may interfere with incorporated external dyes. Due to the overlapping spectra, the origin of the fluorescence in microscopic images cannot be easily distinguished by signal intensity alone. Recording spectral information along with intensity images would help in the identification. Some approaches for recording spectral information by means of hyperspectral setups can be found in the literature.

Previous studies describe the penetration of fluorophores into skin, skin tumor and irradiation investigations and the assessment of bruised and traumatic skin injuries.1415.16.17.18.19 Numerous further reports on spectral imaging that do not cover skin research are available.2021.22.23.24

In this work we present a new confocal imaging approach with microscopic spatial resolution to visualize spectral information in tissue. The appropriate image processing steps based on normalized cross-correlation and the derivation of a new quantitative measure is described. The method is tested in the context of pharmaceutical development of drug delivery systems. In this study it is used to localize and evaluate fluorescent dyes in vertical slices of excised porcine skin to quantify uptake efficiency of a submicron emulsion for dermal transport. Although the method is discussed in the field of pharmaceutics, the method can be useful in more general applications in life-science imaging. Therefore, in addition to the presented in vitro considerations, potential in vivo applications are discussed.

2.

Material and Methods

2.1.

Fluorescent Probe and Skin Autofluorescence

Nile Red (Sigma-Aldrich, Germany) was used as a lipophilic fluorescent dye in the prepared submicron emulsion. The fluorescence spectrum of Nile Red remains stable over a wide pH range while influenced by the polarity of its solvents.25 Figure 1 shows the emissions spectra of the dye, solved in 70% ethanol, in comparison to natural porcine skin measured by the confocal laser-scanning microscope. Nile Red has an emission peak at 580 nm excited with the 476 nm line of an argon laser. The broad autofluorescence spectrum of skin exists due to the numerous intrinsic fluorophores.

Fig. 1

Emission spectra of untreated porcine skin and the fluorescent dye Nile Red (Excitation: 476 nm). The spectral data was measured using the confocal microscope. The normalized presentation of the data shows the distinguishable emission peaks and the spectral overlap.

JBO_17_10_106011_f001.png

2.2.

Drug Delivery System Preparation

Submicron emulsions were chosen as a delivery system because they have shown to enhance the penetration of substances into skin due to their particle size and surfactants.26 Submicron emulsions are oil-in-water emulsions with a droplet size below one micrometer. It is a kinetic stable emulsion in which the droplet size is achieved by an incorporation of emulsifiers.27 The oil phase consisted of oleth-3, -10, ethyloleat (Croda, Germany), coco-caprylat/caprat, cetearyl isononanoat (Cognis, Germany) and 0.002% Nile Red, while the aqueous phase consisted of sodium chloride, citric acid, potassium sorbate (Fagron, Germany), magnesium sulfate and glycerol (Caelo, Germany). The surfactant concentration was adjusted to achieve a hydrophilic-lipophilic balance value of 11. All ingredients obtained were of pharmaceutical grade. The physico-chemical properties were recorded to characterize the delivery system. The dynamic light scattering analyzing method (Zetasizer Nano ZS 90, Malvern Instruments, UK) showed a z-average size of 258±3nm with a polydispersity index of 0.16±0.01. The viscosity of 2.4±0.2mPa·s was determined by RheoStress 300 Rheometer (ThermoHaake, Germany). Due to the preservation with potassium sorbate, the pH value was adjusted to 4.8±0.2.

2.3.

Porcine Skin Samples

Porcine ear skin is quite similar to human skin and was therefore used in this study.28 Fresh ears of domestic pigs were obtained from a local abattoir and kept on ice during transport to the laboratory. After slaughtering, porcine ears were cleaned with water and shaved to remove the bristles. The full thickness skin was displaced with a scalpel and stored at 20°C for less than three months.

Two preparation methods were used to obtain reference skin samples for validation measurements and penetration skin samples. The latter were used for the penetration study that evaluates delivery system performance.

2.4.

Reference Skin Samples

The frozen skin specimens were cut into 10-μm thick slices using a cryo-microtom (Leica Microsystems, Germany) and then transferred into 70% ethanol with different Nile Red concentrations for 10 min. The dye was soaked up and excessive dye was removed from the skin under flowing water. The dye concentrations (0.2, 1, and 2μg/mL) were chosen to cover a common recovery range of agents in the specimens of drug penetration studies. These reference skin samples were used to derive the sensitivity of the imaging scheme.

2.5.

Penetration Skin Samples

The penetration of Nile Red into skin was performed on a Franz diffusion cell setup. On the day of experiment the frozen skin was thawed and fixed between the donor and receptor chamber of the Franz diffusion cell (Gauer Glas, Puettlingen, Germany). The penetration area had a diameter of 1.767cm2 and was in contact to 12 mL phosphate buffered saline (PBS) temperatured to 32.5 °C on the dermis side. The submicron emulsion was applied as infinite-dose (300 µL) for 3 h, 6 h, 8 h and 24 h to three porcine skin samples each to get a total of 12 experiment samples. After each time period, the skin was removed from the diffusion cell, wiped and washed with 50 mL aqua dest. The specimen was mounted into a freezing medium (Leica, Germany), shock frozen by fluid nitrogen and cut into various 10 μm thick vertical slices in order to prepare penetration samples for microscopy.

2.6.

Spectral Imaging

Spectral imaging was performed using a TCS SP5 confocal laser-scanning microscope (Leica Microsystems, Mannheim, Germany) equipped with a detection unit that allows spectral discrimination to selectively detect narrow wavelength bands. The recorded fluorescence emission region (excitation at 476 nm) starting at 495 nm up to 650 nm (divided into 10 single detection bands that are 20 nm wide) was chosen to cover the spectra of porcine skin and Nile Red. A 0.7 NA water immersion objective (20×) was used and the image resolution was set to 512×512pixel with a pixel size of 1.51μm2, resulting in a field of view of 775×775μm2. The generated image stacks were of the dimensions xyλ. The reference spectrum of Nile Red was recorded in the same way. Figures 2 and 3 give an overview of a 24 h penetration sample in comparison to natural (untreated) skin. The series of λ-stack pictures and an exemplary spectrum of the selected regions of interest (ROI) are shown to illustrate the different spectra. These spectral differences are used for the image processing scheme.

Fig. 2

Overview (a), images of the λ-stack (b) and spectra of ROI 1 and 2 (c) of a 24 h penetration skin sample. The given wavelengths of the λ-stack describe the center of the 20 nm wide wavebands.

JBO_17_10_106011_f002.png

Fig. 3

Overview (a), images of the λ-Stack, (b) spectra of ROI 1 and 2, (c) of an untreated skin sample. The given wavelengths of the λ-stack describe the center of the 20 nm wide wavebands.

JBO_17_10_106011_f003.png

2.7.

Image Processing Scheme

The image processing starts with the application of a threshold to exclude pixels with low intensities. The background or noisy image regions are excluded from the calculations. In the next step, the intensity data are normalized along the λ-axis to calculate intensity independent spectra for each image pixel. The normalized cross correlation (CC) metric is used to quantify the similarity between the normalized sample spectra and the reference spectra of Nile Red.

(1)

CC=[SRef(i)SRef¯]*[SSample(i)SSample¯]{[SRef(i)SRef¯]2}*{[SSample(i)SSample¯]2},
where Sref(i) is the normalized intensity at position i of the reference spectrum, Ssample(i) is the normalized intensity at position i of the sample spectrum, Sref¯ is the mean intensity value of the normalized reference spectrum and Ssample¯ is the mean intensity value of the normalized sample spectrum.

The resulting correlation coefficient map of the image is built on the spectral information in the sample and is therefore based on dye distribution. Hereby, the highest CC value of one represents complete accordance between sample and reference spectrum. Decreasing CC values indicate decreasing correlation of the spectra.

To enable a comparison of the different images, the uptake indicator UIx is introduced. It represents the quantity of coefficients higher than a threshold normalized to the total number of pixels representing tissue.

(2)

UIx=Number of correlation coefficients higherxNumber of tissue pixels
These tissue pixels are derived by calculating the standard deviation of the normalized spectral data for every pixel. A uniformly distributed intensity profile along the λ-axis indicates background pixels that are not included in the calculations.

Because UIx depends on an arbitrary threshold, two evaluation experiments were carried out. In the first experiment untreated skin samples were used to calculate the fraction that is false positively classified as Nile Red pixels with increasing threshold values (see Table 1).

Table 1

Measurements of untreated skin samples (n=5) for the evaluation of the 0 parameter.

UI0.4UI0.5UI0.6UI0.7UI0.8UI0.9
Mean (%)3.6.9.4.09.02.0002
StdDev (%).9.4.1.03.01.0002

Table 2

Presentation of the skin penetration results in mean UI0.8 and standard deviation for the four time periods.

UI0.83 h6 h8 h24 h
Mean (%)0.71.53.013.8
StdDev (%)0.61.12.64.8

Table 1 indicates the fraction of pixels of an untreated skin sample that are false positively calculated to be similar to the dye reference spectrum.

In the second experiment the reference skin samples were used to evaluate the highest threshold that allows a clear discrimination between the used concentrations.

Figure 4 shows the results of the reference samples indicating that UI0.9 is not suitable to allow discrimination of the two lowest concentrations, whereas it is possible when using UI0.8. Considering the very low false positive classification of. 02%, UI0.8 was used as the evaluation parameter for further experiments.

Fig. 4

Determination of the appropriate value for UIx. The graph shows the UI0.7, UI0.8 and UI0.9 values for 0.2μg/mL, 1μg/mL and 2μg/mL Nile Red reference skin samples. It is not possible to discriminate the 0.2μg/mL and 1μg/mL sample when using UI0.9.

JBO_17_10_106011_f004.png

2.8.

Validation Measurements

To confirm that the scheme is not depending on absolute intensity values, the samples were imaged with different intensification by varying photomultiplier (PMT) voltages in a range from 500 V to 1200 V in eight steps. UI0.8 was calculated for every image and was expected to be constant for different image intensity levels. For the second experiment the focal depth was changed during imaging of two skin samples and UI0.8 was calculated to assess the influence of focusing.

3.

Results

3.1.

Scheme Validation

The results of the validation experiment for varying signal intensities are shown in Fig. 5(a). Regarding the variation of the PMT voltage to modify the image intensity, UI0.8 is nearly constant over a 200 to 300 V region for the 24 h and 8 h samples. The UI0.8 increase at 500 to 600 V can be explained with the very low overall intensity of the spectral images at 500 V. Thus, the spectra cannot be properly measured. The UI0.8 decrease starting at 900 to 1000 V can be observed due to a strong signal saturation effect in single spectral bands for the 8 h and 24 h samples. Therefore, the spectral information is lost because of detector saturation. The 6 h sample has a UI0.8 value that is constant over the range of 600 to 1200 V.

Fig. 5

The graphs show the results of the varying PMT (a) and focus (b) settings. The image sequences illustrate the changes in the data when varying the PMT voltage and the focus depth, respectively.

JBO_17_10_106011_f005.png

These measurements indicate that the UI0.8 values do not change significantly over a broad intensity interval when using reasonable imaging parameters.

Focus position, in contrast, is a very sensitive parameter. The graph in Fig. 5(b) shows a Gaussian-like distribution of UI0.8 with varying focus depths for the 10 µm thick sample. The measurements indicate that it is important to focus carefully for getting reliable results. Considering the moderate UI0.8 change around the 1μm to 1 µm relative focus position, a roughly 3-μm tolerance margin for focusing can be supposed.

3.2.

Skin Penetration Study

The results of the penetration study show a strong time dependence of dye uptake in skin (see Fig. 6 and Table 2). The assessment of this uptake using the UI0.8 parameter allows the quantitative comparison of the four time periods. It shows that the 24 h samples have a more than four times higher mean UI0.8 value compared to the 8 h samples.

Fig. 6

Skin penetration study results (n=20 per penetration period). Data are presented in mean ±SD. *P<0.05 and ***P<0.001 evaluated by paired Student’s t-test. The 24 h samples show a significantly higher uptake of Nile Red.

JBO_17_10_106011_f006.png

The overlay intensity-based images and the spectrally resolved dye distribution are shown in Fig. 7. The intensity-based images were recorded with optimized parameters to achieve high image quality. The dye distribution was visualized using the correlation coefficient map and the UI0.8 parameter as a threshold. The epidermal skin layer can be distinguished from the lower dermal layer due to its bright gray appearance. The darker dermal layer, however, shows brighter structures throughout the whole area. Dye distribution, shown in red, indicates that for the 3 h, 6 h and 8 h samples, the uptake does not cover the whole epidermis in the way that the UI0.8 criteria is fulfilled. The 24 h sample shows complete uptake in the epidermis and additional uptake in the dermis layer.

Fig. 7

Overlay of the intensity based confocal images of the skin and the spectrally resolved dye distribution (shown in red, please refer to the online version of this manuscript) for the four time periods.

JBO_17_10_106011_f007.png

4.

Discussion

It was shown that a spectrally resolved imaging and processing method can be used to assess and compare spectral information in tissue. The processing scheme calculates the introduced uptake indicator that derives from spectral correlation analysis. It can be used for mapping spectral information in microscopic images of tissue. The method is developed and validated in the context of a very frequently performed penetration experiment according to the OECD Guidelines for Testing of Chemicals in pharmaceutical research. However, the scope of the method is not limited to drug delivery studies but can be transferred to further applications that need spectral discrimination at a microscopic scale.

4.1.

Pharmaceutical In Vitro Experiments

High dermal transport is important to address skin diseases occurring in the upper layers. Tape-stripping methods are commonly used to stepwise ablate small parts of the outer skin for quantitatively analyze depth profiles.29 However, it is limited to the stratum corneum and does not give any information of the homogeneity and the distribution of drugs in the skin layer itself. In contrast, microscopic evaluation of vertical slices has the capability to show profiles directly throughout the whole skin, but lacks the possibility to quantify the amount of penetrated substances. Schmidts30 presented a skin penetration study that correlated an ELISA based quantification with an intensity-based microscopy evaluation method. The results were of good qualitative accordance indicating the suitability of the microscopy approach for evaluating dermal delivery systems. The developed uptake indicator of this paper was a consequent advancement of Schmidts’ microscopy analysis. It allows indirect quantitative measurements and is a step towards the quantitative evaluation of dermal delivery systems and processes. The results of the presented penetration study support this statement as they show a clear discrimination of the four time periods.

Our proposed method may also be beneficial to studies involving applications of spectral and hyperspectral imaging of penetration studies. Roberts; et al.; performed delivery studies using a FLIM multiphoton system4 that is capable of spectrally detecting fluorescence signal to compare liposome systems. They concluded that the deformability of the liposomes increases penetration based on visual evaluation. In this case, the uptake indicator could be used to obtain comparable results and further increase insight into underlying penetration processes.

Hernandez-Palacios14 introduced a hyperspectral camera system with 20 µm spatial resolution to evaluate penetration studies. The hyperspectral camera detected the emission peak of Alexa 488 (518 to 524 nm) and therefore avoided the use of fluorescence filters. However, the evaluation is based on the fluorescence intensity that is composed of Alexa dye and skin autofluorescence background. Skin structures like melanin and keratin, with an emission peak at 520 nm,2,4 contribute to this intensity. Subtraction of a constant offset value compensates the overlaying signal. Figure 7 illustrates that, when using microscopic resolution, structures of the skin are brightly visible that are not covered with dye. In this case, the overlapping and superimposing signal of the skin and dye vary depending on microscopic structures that are not equally distributed. Hence, a constant autofluorescent background offset cannot be defined and mapping of the dye based on intensity in the microscopic scale is not possible.

4.2.

Advantages and Drawbacks for Delivery Studies

The spectral imaging scheme has several benefits. Additional to the advantage of accurate dye mapping, spectral analysis is superior to intensity-based methods in terms of experiment procedures because it does not require standardized imaging. In general, the emission intensity in confocal microscopy depends on various parameters. Therefore, when using intensity-based methods, it is a comprehensive but very important task to use constant settings in order to assure the comparability of the results. This standardization process requires the assessment and control of imaging setup and sample conditions. While the setup may be kept constant for a whole experiment with certain effort, the sample conditions cannot be controlled easily due to their biological nature.

It is known that the pH-value changes in different skin layers31 and may influence the intensity of dyes that have a strong pH-dependency. Apart from the pH value, fluorescence emission can also be affected by polarity. In the case of Nile Red, the fluorescence is unaffected by pH-values between 4.5 and 8.5 but the emission peak shifts depending on the polarity of the environment.25 A possible shift must be considered for choosing the appropriate reference spectrum for image processing calculations. Additionally, photobleaching is a serious problem that requires attention. Borgia6 reports a 4 to 16% bleaching rate after a one second illumination of Nile Red. It is concluded that the images have to be taken within 10 ms to avoid a strong signal variation.

The spectral data do not depend on absolute intensity values but on relative intensity changes between single wavebands. Consequently they are less sensitive to condition variations and photobleaching resulting in a high robustness of the calculated results. Figure 5 shows that the calculated assessment parameter is constant for reasonable changes of the imaging parameters. This allows measuring every sample with individual settings without the need to use standardized imaging parameters for comparing the results. The advantage is a broad, analyzable concentration range of fluorescent dye in skin specimens. This is especially useful for comparing completely independent experiment setups.

Another advantage of the spectral method is that it is still applicable whenever dyes with emission spectra that are clearly separated from the skin spectrum are not available. Although the spectra overlap, an explicit correlation to either dye or tissue can still be performed. As a result, a reliable assessment of the spatial distribution of dye in tissue is possible.

The UI0.8 parameter that is chosen for the evaluation of the penetration study is an arbitrary measure. It is important to understand that it cannot be used to quantitatively assess the total amount of dye in skin. Due to the overlapping dye and skin spectra, it is difficult to determine the exact correlation coefficient that describes the transition between the two possible signal origins. The UI0.x parameters are used to arbitrarily classify the calculation results into dye and tissue pixels according to a threshold value. For this reason the proposed spectral method is not applicable for tasks that need exact quantitative results. In these cases intensity-based methods can be used that need to be calibrated or intensity corrected. Monte Carlo simulations that determine and compensate for effects of signal attenuation due to scattering and absorption32 are often applied for these applications. Combining these techniques with the spectral evaluation for penetration studies would add valuable information to the localization and penetration depth of dye and agents.

4.3.

Pharmaceutical In Vivo Experiments

It is arguable that in vitro results can be used to assess delivery systems designed for in vivo use. No clear data is available in the literature as there are many studies with good and poor correlation between in vitro and in vivo results.33 Therefore, in vitro results for drug delivery cannot be transferred directly to in vivo considerations without further investigation. For this reason, studies are performed with a parallel in vivo/in vitro setup3435.36 using living mice for the application and penetration of delivery systems and substances. The mice either are sacrificed or biopsies are taken for analysis afterwards. An approach for in vivo imaging without sacrificing the animals is the use of animal window models.37,38 Here, the living animal can be microscopically examined directly through windows that are surgically inserted into the region of interest. Whenever living animals are observed motion artifacts have to be considered and either fixation or synchronizing the scanning system to the heartbeat needs to be performed. Amornphimoltham39 reviewed further in vivo applications for drug delivery research and showed the technical efforts that have to be made for data acquisition.

4.4.

Feasibility for Clinical In Vivo Applications

Gareau40 presented an approach of in vivo confocal reflectance microscopy for the detection of early-stage melanoma of murine skin without further surgical interventions. Lange-Asschenfeld41 and Caspers42 showed confocal laser-scanning microscopes for in vivo imaging of human skin morphology and wound healing. Both studies mention the potential use for pharmaceutical research on drug delivery. A combination of the proposed microscope setup and our spectrally resolved detection unit could be used for optical sectioning and evaluation of fluorescent dyes in living tissue. Additionally, the in vivo microscopy scheme presented by Gareau combined with our proposed spectral uptake indicator could be used in clinical applications like melanoma detection presented by Kuzmina15 for monitoring size and shape variations.

Extending established microscopic in vivo imaging schemes with our proposed spectral evaluation method has the chance to provide additional information for pharmaceutical and clinical applications. However, further investigation is necessary to validate these potential approaches.

Acknowledgments

We would like to thank the Hessen State Ministry of Higher Education, Research and the Arts for the financial support within the Hessen initiative for scientific and economic excellence (LOEWE-Program).

References

1. 

R. Alvarez-Románet al., “Visualization of skin penetration using confocal laser scanning microscopy,” Eur. J. Pharm. Biopharm. 58(2), 301–316 (2004).EJPBEL0939-6411http://dx.doi.org/10.1016/j.ejpb.2004.03.027Google Scholar

2. 

K. Schenke-Laylandet al., “Two-photon microscopes and in vivo multiphoton tomographs—powerful diagnostic tools for tissue engineering and drug delivery,” Advanced Drug Delivery Reviews 58(7), 878–896 (2006).ADDREP0169-409Xhttp://dx.doi.org/10.1016/j.addr.2006.07.004Google Scholar

3. 

S.-J. LinS.-H. JeeC.-Y. Dong, “Multiphoton microscopy: a new paradigm in dermatological imaging,” Eur. J. Dermatol. 17(5), 361–366 (2007).EJDEE41167-1122http://dx.doi.org/10.1684/ejd.2007.0232Google Scholar

4. 

M. S. Robertset al., “Non-invasive imaging of skin physiology and percutaneous penetration using fluorescence spectral and lifetime imaging with multiphoton and confocal microscopy,” Eur. J. Pharm. Biopharm. 77(3), 469–488 (2011).EJPBEL0939-6411http://dx.doi.org/10.1016/j.ejpb.2010.12.023Google Scholar

5. 

H. I. Laboutaet al., “Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles,” Int. J. Pharm. 413(1–2), 279–282 (2011).IJPHDE0378-5173http://dx.doi.org/10.1016/j.ijpharm.2011.03.067Google Scholar

6. 

S. L. Borgiaet al., “Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy,” J. Contr. Release 110(1), 151–163 (2005).JCREEC0168-3659http://dx.doi.org/10.1016/j.jconrel.2005.09.045Google Scholar

7. 

M. R. PrausnitzR. Langer, “Transdermal drug delivery,” Nat. Biotechnol. 26(11), 1261–1268 (2008).NABIF91087-0156http://dx.doi.org/10.1038/nbt.1504Google Scholar

8. 

P. L. Honeywell-NguyenJ. A. Bouwstra, “Vesicles as a tool for transdermal and dermal delivery,” Drug Discov. Today Tech. 2(1), 67–74 (2005).1740-6749http://dx.doi.org/10.1016/j.ddtec.2005.05.003Google Scholar

9. 

R. H. H. Neubert, “Potentials of new nanocarriers for dermal and transdermal drug delivery,” Eur. J. Pharm. Biopharm. 77(1), 1–2 (2011).EJPBEL0939-6411http://dx.doi.org/10.1016/j.ejpb.2010.11.003Google Scholar

10. 

M. Kreilgaard, “Influence of microemulsions on cutaneous drug delivery,” Advanced Drug Delivery Reviews 54(Suppl. 1), S77–S98 (2002).ADDREP0169-409Xhttp://dx.doi.org/10.1016/S0169-409X(02)00116-3Google Scholar

11. 

M. KreilgaardE. J. PedersenJ. W. Jaroszewski, “NMR characterisation and transdermal drug delivery potential of microemulsion systems,” J. Contr. Release 69(3), 421–433 (2000).JCREEC0168-3659http://dx.doi.org/10.1016/S0168-3659(00)00325-4Google Scholar

12. 

M. J. LawrenceG. D. Rees, “Microemulsion-based media as novel drug delivery systems,” Advanced Drug Delivery Reviews 45(1), 89–121 (2000).ADDREP0169-409Xhttp://dx.doi.org/10.1016/S0169-409X(00)00103-4Google Scholar

13. 

T. W. Prowet al., “Nanoparticles and microparticles for skin drug delivery,” Advanced Drug Delivery Reviews 63(6), 470–491 (2011).ADDREP0169-409Xhttp://dx.doi.org/10.1016/j.addr.2011.01.012Google Scholar

14. 

J. Hernandez-Palacioset al., “Hyperspectral characterization of fluorophore diffusion in human skin using a sCMOS based hyperspectral camera,” Proc. SPIE 8087, 808717 (2011).PSISDG0277-786Xhttp://dx.doi.org/10.1117/12.889816Google Scholar

15. 

I. Kuzminaet al., “Towards noncontact skin melanoma selection by multispectral imaging analysis,” J. Biomed. Opt. 16(6), 060502 (2011).JBOPFO1083-3668http://dx.doi.org/10.1117/1.3584846Google Scholar

16. 

S.-G. Kong, “Inspection of poultry skin tumor using hyperspectral fluorescence imaging,” Proc. SPIE 5132, 455–463 (2003).PSISDG0277-786Xhttp://dx.doi.org/10.1117/12.515151Google Scholar

17. 

M. S. Chinet al., “Hyperspectral imaging for early detection of oxygenation and perfusion changes in irradiated skin,” J. Biomed. Opt. 17(2), 026010 (2012).JBOPFO1083-3668http://dx.doi.org/10.1117/1.JBO.17.2.026010Google Scholar

18. 

L. L. Randeberg, “Hyperspectral imaging of bruised skin,” Proc. SPIE 6078, 60780O (2006).PSISDG0277-786Xhttp://dx.doi.org/10.1117/12.646557Google Scholar

19. 

L. L. Randeberget al., “In vivo hyperspectral imaging of traumatic skin injuries in a porcine model,” Proc. SPIE 6424, 642408 (2012).PSISDG0277-786Xhttp://dx.doi.org/10.1117/12.699380Google Scholar

20. 

J. M. Beach, “Portable hyperspectral imager for assessment of skin disorders: preliminary measurements,” Proc. SPIE 5686, 111–118 (2005).PSISDG0277-786Xhttp://dx.doi.org/10.1117/12.590938Google Scholar

21. 

B. Parket al., “AOTF hyperspectral microscopic imaging for foodborne pathogenic bacteria detection,” Proc. SPIE 8027, 802707 (2011).PSISDG0277-786Xhttp://dx.doi.org/10.1117/12.884012Google Scholar

22. 

R. AroraG. I. PetrovV. V. Yakovlev, “Hyperspectral coherent anti-Stokes Raman scattering microscopy imaging through turbid medium,” J. Biomed. Opt. 16(2), 021116 (2011).JBOPFO1083-3668http://dx.doi.org/10.1117/1.3541796Google Scholar

23. 

G. N. StamatasN. Kollias, “In vivo documentation of cutaneous inflammation using spectral imaging,” J. Biomed. Opt. 12(5), 051603 (2007).JBOPFO1083-3668http://dx.doi.org/10.1117/1.2798704Google Scholar

24. 

C. Zakianet al., “In vivo quantification of gingival inflammation using spectral imaging,” J. Biomed. Opt. 13(5), 054045 (2008).JBOPFO1083-3668http://dx.doi.org/10.1117/1.2982536Google Scholar

25. 

D. L. SackettJ. Wolff, “Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces,” Anal. Biochem. 167(2), 228–234 (1987).ANBCA20003-2697http://dx.doi.org/10.1016/0003-2697(87)90157-6Google Scholar

26. 

D. I. FriedmanJ. S. SchwarzM. Weisspapir, “Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs,” J. Pharm. Sci. 84(3), 324–329 (1995).JPMSAE0022-3549http://dx.doi.org/10.1002/(ISSN)1520-6017Google Scholar

27. 

T. Schmidts, “Protective effect of drug delivery systems against the enzymatic degradation of dermally applied DNAzyme,” Inter. J. Pharm. 410(1–2), 75–82 (2011).IJPHDE0378-5173http://dx.doi.org/10.1016/j.ijpharm.2011.03.023Google Scholar

28. 

C. Herkenneet al., “Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man,” Pharm. Res. 23(8), 1850–1856 (2006).PHREEB0724-8741http://dx.doi.org/10.1007/s11095-006-9011-8Google Scholar

29. 

J. Lademannet al., “The tape stripping procedure—evaluation of some critical parameters,” Eur. J. Pharm. Biopharm. 72(2), 317–323 (2009).EJPBEL0939-6411http://dx.doi.org/10.1016/j.ejpb.2008.08.008Google Scholar

30. 

T. Schmidtset al., “Development of drug delivery systems for the dermal application of therapeutic DNAzymes,” Inter. J. Pharm. 431(1–2), 61–69 (2012).IJPHDE0378-5173http://dx.doi.org/10.1016/j.ijpharm.2012.04.034Google Scholar

31. 

H. Wagneret al., “pH profiles in human skin: influence of two in vitro test systems for drug delivery testing,” Eur. J. Pharm. Biopharm. 55(1), 57–65 (2003).EJPBEL0939-6411http://dx.doi.org/10.1016/S0939-6411(02)00125-XGoogle Scholar

32. 

U. Maeder, “Feasibility of Monte Carlo simulations in quantitative tissue imaging,” International Journal of Artifical Organs 33(4), 253–259 (2010).0391-3988Google Scholar

33. 

B. GodinE. Touitou, “Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models,” Advanced Drug Delivery Reviews 59(11), 1152–1161 (2007).ADDREP0169-409Xhttp://dx.doi.org/10.1016/j.addr.2007.07.004Google Scholar

34. 

Z.-R. Huanget al., “In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein,” Inter. J. Pharm. 364(1), 36–44 (2008).IJPHDE0378-5173http://dx.doi.org/10.1016/j.ijpharm.2008.08.002Google Scholar

35. 

F. C. Rossetti, “A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy,” J. Contr. Release 155(3), 400–408 (2011).JCREEC0168-3659http://dx.doi.org/10.1016/j.jconrel.2011.06.034Google Scholar

36. 

M. E. M. J van Kuijk-Meuwissenet al., “Application of vesicles to rat skin in vivo: a confocal laser scanning microscopy study,” J. Contr. Release 56(1–3), 189–196 (1998).JCREEC0168-3659http://dx.doi.org/10.1016/S0168-3659(98)00087-XGoogle Scholar

37. 

M.-A. Abdul-Karimet al., “Automated tracing and change analysis of angiogenic vasculature from in vivo multiphoton confocal image time series,” Microvascular Research 66(2), 113–125 (2003).MIVRA60026-2862http://dx.doi.org/10.1016/S0026-2862(03)00039-6Google Scholar

38. 

S. Schlosseret al., “Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin,” Microvasc. Res. 83(3), 267–275 (2012).MIVRA60026-2862http://dx.doi.org/10.1016/j.mvr.2012.02.011Google Scholar

39. 

P. AmornphimolthamA. MasedunskasR. Weigert, “Intravital microscopy as a tool to study drug delivery in preclinical studies,” Advanced Drug Delivery Reviews 63(1–2), 119–128 (2011).ADDREP0169-409Xhttp://dx.doi.org/10.1016/j.addr.2010.09.009Google Scholar

40. 

D. S. Gareauet al., “Noninvasive imaging of melanoma with reflectance mode confocal scanning laser microscopy in a murine model,” J. Investig. Dermatol. 127(9), 2184–2190 (2007).0022-202Xhttp://dx.doi.org/10.1038/sj.jid.5700829Google Scholar

41. 

S. Lange-Asschenfeldtet al., “Applicability of confocal laser scanning microscopy for evaluation and monitoring of cutaneous wound healing,” J. Biomed. Opt. 17(7), 076016 (2012).JBOPFO1083-3668http://dx.doi.org/10.1117/1.JBO.17.7.076016Google Scholar

42. 

P. J. CaspersG. W. LucassenG. J. Puppels, “Combined in vivo confocal Raman spectroscopy and confocal microscopy of human skin,” Biophys J. 85(1), 572–580 (2003).0006-3495http://dx.doi.org/10.1016/S0006-3495(03)74501-9Google Scholar

Ulf Maeder, Kay Marquardt, Sebastian Beer, Thorsten Bergmann, Thomas Schmidts, Johannes T. Heverhagen, Klemens Zink, Frank Runkel, Martin Fiebich, "Evaluation and quantification of spectral information in tissue by confocal microscopy," Journal of Biomedical Optics 17(10), 106011 (1 October 2012). http://dx.doi.org/10.1117/1.JBO.17.10.106011
JOURNAL ARTICLE
8 PAGES


SHARE
KEYWORDS
Skin

Tissues

Confocal microscopy

In vivo imaging

In vitro testing

Visualization

Image processing

RELATED CONTENT

Effects of temperature on fluorescence in human tissue
Proceedings of SPIE (February 23 2010)

Back to Top